My ePortfolio Register   

The role of health economics in cancer outcomes research

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 06.01.15
Views: 3188

Prof Bengt Jönsson, Stockholm School of Economics, Stockholm, Sweden

Dr Jonsson speaks to ecancer at the 2nd EurocanPlatform Translational Research Course, discussing his presentation into the economic aspects of the final stage in translational cancer research: outcomes research.

He notes the variations between and even within countries and the importance of ascertaining ‘value for money’ in terms of clinical drug use.

He also explores what changes this work could make to clinical practise, what the next steps are and what obstacles pose problems.

Learn more about the EurocanPlatform project here

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence